Active — Not RecruitingNot Applicable

Electroporation for Treatment of Atrial Fibrillation

Slovenia50 participantsStarted 2023-12-05

Plain-language summary

Comparison of pulmonary vein and left atrial posterior wall isolation durability and clinical outcome between radiofrequency and pulse field ablation in patients with persistent and longstanding persistent atrial fibrillation.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * atrial fibrillation recorded with 12-lead ECG, holter ECG or implantable device on two occasions at least one week apart Exclusion Criteria: * history of previous catheter ablation, history of previous heart surgery, life expectancy less than one year, any lifethreatening severe acute condition, acute deep venous thrombosis, presence of intracardiac masses or thrombi.

What they're measuring

Durability of isolation

Timeframe: 3 months

Trial details

NCT IDNCT06134752

SponsorUniversity Medical Centre Ljubljana

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02-15

View on ClinicalTrials.gov More Persistent Atrial Fibrillation trials